Biogen Inc (BIIB)

Current ratio

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total current assets	US$ in thousands	7,456,800	6,859,300	9,791,200	7,856,500	6,887,100
Total current liabilities	US$ in thousands	5,528,800	3,434,300	3,272,800	4,298,200	3,742,200
Current ratio		1.35	2.00	2.99	1.83	1.84

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $7,456,800K ÷ $5,528,800K
= 1.35

The current ratio of Biogen Inc has shown some fluctuations over the years based on the available data:

- As of December 31, 2020, the current ratio was 1.84, indicating that the company had $1.84 in current assets for every $1 in current liabilities. This suggests a relatively healthy liquidity position.

- By December 31, 2021, the current ratio slightly decreased to 1.83, still indicating a strong ability to cover short-term obligations with current assets.

- The current ratio significantly improved by December 31, 2022, reaching 2.99, which suggests a substantial increase in liquidity and the ability to cover short-term liabilities more comfortably.

- However, by December 31, 2023, the current ratio decreased to 2.00, which, while still above 1, indicates a slight decline in liquidity compared to the previous year.

- By December 31, 2024, the current ratio further decreased to 1.35. While this ratio is still above 1, it indicates a potential decrease in the company's ability to cover short-term obligations with current assets, which may warrant further investigation into the company's liquidity management.

Overall, Biogen Inc's current ratio has shown variability over the years, with some periods indicating strong liquidity positions and others reflecting potential challenges in meeting short-term obligations with current assets. It is essential for stakeholders to monitor these fluctuations closely to assess the company's financial health and liquidity management strategies.